Showing results (111-120 of 199) with videos related to
Sort By:
Pageof 20
Lancet (London, England)|March 12, 1999
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsG P Aithal, C P Day, P J Kesteven, et al.Lancet (London, England)|June 5, 1993
QT prolongation and sudden cardiac death in patients with alcoholic liver diseaseC P Day, O F James, T J Butler, et al.Lancet (London, England)|September 18, 2001
Mycophenolate mofetil monotherapy in liver transplantationS F Stewart, M Hudson, D Talbot, et al.Biochimie|April 12, 2005
Relationship between the inhibition of phosphatidic acid phosphohydrolase-1 by oleate and oleoyl-CoA ester and its apparent translocationN Elabbadi, C P Day, A Gamouh, et al.Cardiovascular and Interventional Radiology|October 13, 2006
Spontaneous rupture of the hepatic artery in a patient with type 1 neurofibromatosis treated by embolization: a case reportV Rao, C P Day, N Manimaran, et al.Journal of the American College of Cardiology|September 1, 1984
Studies on left ventricular function during sustained ventricular tachycardiaS Saksena, J M Ciccone, W Craelius, et al.American Heart Journal|July 1, 1986
Laser ablation of normal and diseased human ventricleS Saksena, J M Ciccone, P Chandran, et al.The American Journal of Cardiology|February 1, 1997
Right and left ventricular hemodynamic performance during sustained ventricular tachycardiaT M Kolettis, S Saksena, P Mathew, et al.The American Journal of Cardiology|July 1, 1986
Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardiaS Saksena, D Pantopoulos, V Parsonnet, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 15, 2007
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open questionP Loria, A Lonardo, S Bellentani, et al.Pageof 20